Lazaro Gil Gonzalez

8PUBLICATIONS
20CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Foetal development and medicineAutoimmunityElectrical energy generation (incl. renewables, excl. photovoltaics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 31, 2026
FcγRIII blockade prevents anti-HLA-mediated platelet clearance in a humanized murine model of platelet transfusion refractoriness.

|Jun 10, 2026
Inhibition of human FcγRIII prevents platelet destruction in a dual-humanized murine model of FNAIT.

|Mar 20, 2024
Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice.

Kevin Doyoon Won, Lazaro Gil Gonzalez, Yoelys Cruz-Leal

|Mar 15, 2024
Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice.

Shahryar Khoshtinat Nikkhoi, Ge Yang, Hajar Owji

|Feb 08, 2024
Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP.

Lazaro Gil Gonzalez, Kevin D Won, Zoya Tawhidi

|Nov 10, 2023
Trogocytosis drives red blood cell antigen loss in association with antibody-mediated immune suppression.

Yoelys Cruz-Leal, Peter A A Norris, Lazaro Gil Gonzalez

Pageof 2

Frequent Collaborators

5 joint publications

Alan H Lazarus

4 joint publications

Yoelys Cruz-Leal

3 joint publications

Ulrich J Sachs

2 joint publications

Kevin Doyoon Won